 | • レポートコード：QYR2104Z4626 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、梨状筋症候群のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（投薬、理学療法、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・梨状筋症候群の市場動向 ・企業の競争状況、市場シェア ・梨状筋症候群の種類別市場規模（投薬、理学療法、その他） ・梨状筋症候群の用途別市場規模（病院、診療所、その他） ・梨状筋症候群の北米市場規模2016-2027（アメリカ、カナダ） ・梨状筋症候群のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・梨状筋症候群のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・梨状筋症候群の中南米市場規模2016-2027（メキシコ、ブラジル） ・梨状筋症候群の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、Sanofi、Bayer、AstraZeneca、Teva Pharmaceuticals、Endo Pharmaceuticals、Omron Healthcare、DePuy Synthes、Miracle Stretch、Seirin Corporation、Nidd Valley Medical） ・結論 |
Piriformis syndrome is a rare neuromuscular condition that is caused when the piriformis muscle compresses the sciatic nerve. The piriformis muscle is a flat, band-like muscle located in the buttock near the upper region of the hip joint. Piriformis syndrome mostly occurs in adults and can affect individuals from any field and activity levels. The common causes of piriformis syndrome are considered to be trauma, spasms, and overuse injury. Additionally, according to the National Center for Biotechnology Information (NCBI), the piriformis syndrome is more prevalent in patients with pain in the lower back.
The North American region is anticipated to dominate the market due to the existing well-established healthcare system, increasing healthcare expenditure, growing awareness about the syndrome, and rising geriatric population.
Market Analysis and Insights: Global Piriformis Syndrome Market
The global Piriformis Syndrome market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Piriformis Syndrome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Piriformis Syndrome market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Piriformis Syndrome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Piriformis Syndrome market.
Global Piriformis Syndrome Scope and Market Size
Piriformis Syndrome market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Piriformis Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Medication
Physical Therapy
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novartis
Sanofi
Bayer
AstraZeneca
Teva Pharmaceuticals
Endo Pharmaceuticals
Omron Healthcare
DePuy Synthes
Miracle Stretch
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Piriformis Syndrome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medication
1.2.3 Physical Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Piriformis Syndrome Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Piriformis Syndrome Market Perspective (2016-2027)
2.2 Piriformis Syndrome Growth Trends by Regions
2.2.1 Piriformis Syndrome Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Piriformis Syndrome Historic Market Share by Regions (2016-2021)
2.2.3 Piriformis Syndrome Forecasted Market Size by Regions (2022-2027)
2.3 Piriformis Syndrome Industry Dynamic
2.3.1 Piriformis Syndrome Market Trends
2.3.2 Piriformis Syndrome Market Drivers
2.3.3 Piriformis Syndrome Market Challenges
2.3.4 Piriformis Syndrome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Piriformis Syndrome Players by Revenue
3.1.1 Global Top Piriformis Syndrome Players by Revenue (2016-2021)
3.1.2 Global Piriformis Syndrome Revenue Market Share by Players (2016-2021)
3.2 Global Piriformis Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Piriformis Syndrome Revenue
3.4 Global Piriformis Syndrome Market Concentration Ratio
3.4.1 Global Piriformis Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Piriformis Syndrome Revenue in 2020
3.5 Piriformis Syndrome Key Players Head office and Area Served
3.6 Key Players Piriformis Syndrome Product Solution and Service
3.7 Date of Enter into Piriformis Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Piriformis Syndrome Breakdown Data by Type
4.1 Global Piriformis Syndrome Historic Market Size by Type (2016-2021)
4.2 Global Piriformis Syndrome Forecasted Market Size by Type (2022-2027)
5 Piriformis Syndrome Breakdown Data by Application
5.1 Global Piriformis Syndrome Historic Market Size by Application (2016-2021)
5.2 Global Piriformis Syndrome Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Piriformis Syndrome Market Size (2016-2027)
6.2 North America Piriformis Syndrome Market Size by Type
6.2.1 North America Piriformis Syndrome Market Size by Type (2016-2021)
6.2.2 North America Piriformis Syndrome Market Size by Type (2022-2027)
6.2.3 North America Piriformis Syndrome Market Size by Type (2016-2027)
6.3 North America Piriformis Syndrome Market Size by Application
6.3.1 North America Piriformis Syndrome Market Size by Application (2016-2021)
6.3.2 North America Piriformis Syndrome Market Size by Application (2022-2027)
6.3.3 North America Piriformis Syndrome Market Size by Application (2016-2027)
6.4 North America Piriformis Syndrome Market Size by Country
6.4.1 North America Piriformis Syndrome Market Size by Country (2016-2021)
6.4.2 North America Piriformis Syndrome Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Piriformis Syndrome Market Size (2016-2027)
7.2 Europe Piriformis Syndrome Market Size by Type
7.2.1 Europe Piriformis Syndrome Market Size by Type (2016-2021)
7.2.2 Europe Piriformis Syndrome Market Size by Type (2022-2027)
7.2.3 Europe Piriformis Syndrome Market Size by Type (2016-2027)
7.3 Europe Piriformis Syndrome Market Size by Application
7.3.1 Europe Piriformis Syndrome Market Size by Application (2016-2021)
7.3.2 Europe Piriformis Syndrome Market Size by Application (2022-2027)
7.3.3 Europe Piriformis Syndrome Market Size by Application (2016-2027)
7.4 Europe Piriformis Syndrome Market Size by Country
7.4.1 Europe Piriformis Syndrome Market Size by Country (2016-2021)
7.4.2 Europe Piriformis Syndrome Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Piriformis Syndrome Market Size (2016-2027)
8.2 Asia-Pacific Piriformis Syndrome Market Size by Type
8.2.1 Asia-Pacific Piriformis Syndrome Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Piriformis Syndrome Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Piriformis Syndrome Market Size by Type (2016-2027)
8.3 Asia-Pacific Piriformis Syndrome Market Size by Application
8.3.1 Asia-Pacific Piriformis Syndrome Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Piriformis Syndrome Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Piriformis Syndrome Market Size by Application (2016-2027)
8.4 Asia-Pacific Piriformis Syndrome Market Size by Region
8.4.1 Asia-Pacific Piriformis Syndrome Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Piriformis Syndrome Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Piriformis Syndrome Market Size (2016-2027)
9.2 Latin America Piriformis Syndrome Market Size by Type
9.2.1 Latin America Piriformis Syndrome Market Size by Type (2016-2021)
9.2.2 Latin America Piriformis Syndrome Market Size by Type (2022-2027)
9.2.3 Latin America Piriformis Syndrome Market Size by Type (2016-2027)
9.3 Latin America Piriformis Syndrome Market Size by Application
9.3.1 Latin America Piriformis Syndrome Market Size by Application (2016-2021)
9.3.2 Latin America Piriformis Syndrome Market Size by Application (2022-2027)
9.3.3 Latin America Piriformis Syndrome Market Size by Application (2016-2027)
9.4 Latin America Piriformis Syndrome Market Size by Country
9.4.1 Latin America Piriformis Syndrome Market Size by Country (2016-2021)
9.4.2 Latin America Piriformis Syndrome Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Piriformis Syndrome Market Size (2016-2027)
10.2 Middle East & Africa Piriformis Syndrome Market Size by Type
10.2.1 Middle East & Africa Piriformis Syndrome Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Piriformis Syndrome Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Piriformis Syndrome Market Size by Type (2016-2027)
10.3 Middle East & Africa Piriformis Syndrome Market Size by Application
10.3.1 Middle East & Africa Piriformis Syndrome Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Piriformis Syndrome Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Piriformis Syndrome Market Size by Application (2016-2027)
10.4 Middle East & Africa Piriformis Syndrome Market Size by Country
10.4.1 Middle East & Africa Piriformis Syndrome Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Piriformis Syndrome Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Piriformis Syndrome Introduction
11.1.4 Novartis Revenue in Piriformis Syndrome Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Piriformis Syndrome Introduction
11.2.4 Sanofi Revenue in Piriformis Syndrome Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Piriformis Syndrome Introduction
11.3.4 Bayer Revenue in Piriformis Syndrome Business (2016-2021)
11.3.5 Bayer Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Piriformis Syndrome Introduction
11.4.4 AstraZeneca Revenue in Piriformis Syndrome Business (2016-2021)
11.4.5 AstraZeneca Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Details
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Piriformis Syndrome Introduction
11.5.4 Teva Pharmaceuticals Revenue in Piriformis Syndrome Business (2016-2021)
11.5.5 Teva Pharmaceuticals Recent Development
11.6 Endo Pharmaceuticals
11.6.1 Endo Pharmaceuticals Company Details
11.6.2 Endo Pharmaceuticals Business Overview
11.6.3 Endo Pharmaceuticals Piriformis Syndrome Introduction
11.6.4 Endo Pharmaceuticals Revenue in Piriformis Syndrome Business (2016-2021)
11.6.5 Endo Pharmaceuticals Recent Development
11.7 Omron Healthcare
11.7.1 Omron Healthcare Company Details
11.7.2 Omron Healthcare Business Overview
11.7.3 Omron Healthcare Piriformis Syndrome Introduction
11.7.4 Omron Healthcare Revenue in Piriformis Syndrome Business (2016-2021)
11.7.5 Omron Healthcare Recent Development
11.8 DePuy Synthes
11.8.1 DePuy Synthes Company Details
11.8.2 DePuy Synthes Business Overview
11.8.3 DePuy Synthes Piriformis Syndrome Introduction
11.8.4 DePuy Synthes Revenue in Piriformis Syndrome Business (2016-2021)
11.8.5 DePuy Synthes Recent Development
11.9 Miracle Stretch
11.9.1 Miracle Stretch Company Details
11.9.2 Miracle Stretch Business Overview
11.9.3 Miracle Stretch Piriformis Syndrome Introduction
11.9.4 Miracle Stretch Revenue in Piriformis Syndrome Business (2016-2021)
11.9.5 Miracle Stretch Recent Development
11.10 Seirin Corporation
11.10.1 Seirin Corporation Company Details
11.10.2 Seirin Corporation Business Overview
11.10.3 Seirin Corporation Piriformis Syndrome Introduction
11.10.4 Seirin Corporation Revenue in Piriformis Syndrome Business (2016-2021)
11.10.5 Seirin Corporation Recent Development
11.11 Nidd Valley Medical
11.11.1 Nidd Valley Medical Company Details
11.11.2 Nidd Valley Medical Business Overview
11.11.3 Nidd Valley Medical Piriformis Syndrome Introduction
11.11.4 Nidd Valley Medical Revenue in Piriformis Syndrome Business (2016-2021)
11.11.5 Nidd Valley Medical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Piriformis Syndrome Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medication
Table 3. Key Players of Physical Therapy
Table 4. Key Players of Others
Table 5. Global Piriformis Syndrome Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Piriformis Syndrome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Piriformis Syndrome Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Piriformis Syndrome Market Share by Regions (2016-2021)
Table 9. Global Piriformis Syndrome Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Piriformis Syndrome Market Share by Regions (2022-2027)
Table 11. Piriformis Syndrome Market Trends
Table 12. Piriformis Syndrome Market Drivers
Table 13. Piriformis Syndrome Market Challenges
Table 14. Piriformis Syndrome Market Restraints
Table 15. Global Piriformis Syndrome Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Piriformis Syndrome Market Share by Players (2016-2021)
Table 17. Global Top Piriformis Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Piriformis Syndrome as of 2020)
Table 18. Ranking of Global Top Piriformis Syndrome Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Piriformis Syndrome Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Piriformis Syndrome Product Solution and Service
Table 22. Date of Enter into Piriformis Syndrome Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Piriformis Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Piriformis Syndrome Revenue Market Share by Type (2016-2021)
Table 26. Global Piriformis Syndrome Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Piriformis Syndrome Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Piriformis Syndrome Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Piriformis Syndrome Revenue Market Share by Application (2016-2021)
Table 30. Global Piriformis Syndrome Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Piriformis Syndrome Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Piriformis Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Piriformis Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Piriformis Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Piriformis Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Piriformis Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Piriformis Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Piriformis Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Piriformis Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Piriformis Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Piriformis Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Piriformis Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Piriformis Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Piriformis Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Piriformis Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Piriformis Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Piriformis Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Piriformis Syndrome Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Piriformis Syndrome Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Piriformis Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Piriformis Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Piriformis Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Piriformis Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Piriformis Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Piriformis Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Piriformis Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Piriformis Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Piriformis Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Piriformis Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Piriformis Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Piriformis Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Piriformis Syndrome Product
Table 65. Novartis Revenue in Piriformis Syndrome Business (2016-2021) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Sanofi Company Details
Table 68. Sanofi Business Overview
Table 69. Sanofi Piriformis Syndrome Product
Table 70. Sanofi Revenue in Piriformis Syndrome Business (2016-2021) & (US$ Million)
Table 71. Sanofi Recent Development
Table 72. Bayer Company Details
Table 73. Bayer Business Overview
Table 74. Bayer Piriformis Syndrome Product
Table 75. Bayer Revenue in Piriformis Syndrome Business (2016-2021) & (US$ Million)
Table 76. Bayer Recent Development
Table 77. AstraZeneca Company Details
Table 78. AstraZeneca Business Overview
Table 79. AstraZeneca Piriformis Syndrome Product
Table 80. AstraZeneca Revenue in Piriformis Syndrome Business (2016-2021) & (US$ Million)
Table 81. AstraZeneca Recent Development
Table 82. Teva Pharmaceuticals Company Details
Table 83. Teva Pharmaceuticals Business Overview
Table 84. Teva Pharmaceuticals Piriformis Syndrome Product
Table 85. Teva Pharmaceuticals Revenue in Piriformis Syndrome Business (2016-2021) & (US$ Million)
Table 86. Teva Pharmaceuticals Recent Development
Table 87. Endo Pharmaceuticals Company Details
Table 88. Endo Pharmaceuticals Business Overview
Table 89. Endo Pharmaceuticals Piriformis Syndrome Product
Table 90. Endo Pharmaceuticals Revenue in Piriformis Syndrome Business (2016-2021) & (US$ Million)
Table 91. Endo Pharmaceuticals Recent Development
Table 92. Omron Healthcare Company Details
Table 93. Omron Healthcare Business Overview
Table 94. Omron Healthcare Piriformis Syndrome Product
Table 95. Omron Healthcare Revenue in Piriformis Syndrome Business (2016-2021) & (US$ Million)
Table 96. Omron Healthcare Recent Development
Table 97. DePuy Synthes Company Details
Table 98. DePuy Synthes Business Overview
Table 99. DePuy Synthes Revenue in Piriformis Syndrome Business (2016-2021) & (US$ Million)
Table 100. DePuy Synthes Recent Development
Table 101. Miracle Stretch Company Details
Table 102. Miracle Stretch Business Overview
Table 103. Miracle Stretch Piriformis Syndrome Product
Table 104. Miracle Stretch Revenue in Piriformis Syndrome Business (2016-2021) & (US$ Million)
Table 105. Miracle Stretch Recent Development
Table 106. Seirin Corporation Company Details
Table 107. Seirin Corporation Business Overview
Table 108. Seirin Corporation Piriformis Syndrome Product
Table 109. Seirin Corporation Revenue in Piriformis Syndrome Business (2016-2021) & (US$ Million)
Table 110. Seirin Corporation Recent Development
Table 111. Nidd Valley Medical Company Details
Table 112. Nidd Valley Medical Business Overview
Table 113. Nidd Valley Medical Piriformis Syndrome Product
Table 114. Nidd Valley Medical Revenue in Piriformis Syndrome Business (2016-2021) & (US$ Million)
Table 115. Nidd Valley Medical Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Piriformis Syndrome Market Share by Type: 2020 VS 2027
Figure 2. Medication Features
Figure 3. Physical Therapy Features
Figure 4. Others Features
Figure 5. Global Piriformis Syndrome Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Piriformis Syndrome Report Years Considered
Figure 10. Global Piriformis Syndrome Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Piriformis Syndrome Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Piriformis Syndrome Market Share by Regions: 2020 VS 2027
Figure 13. Global Piriformis Syndrome Market Share by Regions (2022-2027)
Figure 14. Global Piriformis Syndrome Market Share by Players in 2020
Figure 15. Global Top Piriformis Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Piriformis Syndrome as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Piriformis Syndrome Revenue in 2020
Figure 17. Global Piriformis Syndrome Revenue Market Share by Type (2016-2021)
Figure 18. Global Piriformis Syndrome Revenue Market Share by Type (2022-2027)
Figure 19. North America Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Piriformis Syndrome Market Share by Type (2016-2027)
Figure 21. North America Piriformis Syndrome Market Share by Application (2016-2027)
Figure 22. North America Piriformis Syndrome Market Share by Country (2016-2027)
Figure 23. United States Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Piriformis Syndrome Market Share by Type (2016-2027)
Figure 27. Europe Piriformis Syndrome Market Share by Application (2016-2027)
Figure 28. Europe Piriformis Syndrome Market Share by Country (2016-2027)
Figure 29. Germany Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Piriformis Syndrome Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Piriformis Syndrome Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Piriformis Syndrome Market Share by Region (2016-2027)
Figure 39. China Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Piriformis Syndrome Market Share by Type (2016-2027)
Figure 47. Latin America Piriformis Syndrome Market Share by Application (2016-2027)
Figure 48. Latin America Piriformis Syndrome Market Share by Country (2016-2027)
Figure 49. Mexico Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Piriformis Syndrome Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Piriformis Syndrome Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Piriformis Syndrome Market Share by Country (2016-2027)
Figure 55. Turkey Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Piriformis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Novartis Revenue Growth Rate in Piriformis Syndrome Business (2016-2021)
Figure 59. Sanofi Revenue Growth Rate in Piriformis Syndrome Business (2016-2021)
Figure 60. Bayer Revenue Growth Rate in Piriformis Syndrome Business (2016-2021)
Figure 61. AstraZeneca Revenue Growth Rate in Piriformis Syndrome Business (2016-2021)
Figure 62. Teva Pharmaceuticals Revenue Growth Rate in Piriformis Syndrome Business (2016-2021)
Figure 63. Endo Pharmaceuticals Revenue Growth Rate in Piriformis Syndrome Business (2016-2021)
Figure 64. Omron Healthcare Revenue Growth Rate in Piriformis Syndrome Business (2016-2021)
Figure 65. DePuy Synthes Revenue Growth Rate in Piriformis Syndrome Business (2016-2021)
Figure 66. Miracle Stretch Revenue Growth Rate in Piriformis Syndrome Business (2016-2021)
Figure 67. Seirin Corporation Revenue Growth Rate in Piriformis Syndrome Business (2016-2021)
Figure 68. Nidd Valley Medical Revenue Growth Rate in Piriformis Syndrome Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の腫瘍随伴症候群治療市場規模・現状・予測（2021年-2027年） A paraneoplastic syndrome is a rare group of disorder that is triggered by an abnormal immune system response caused by the neoplasm. This syndrome mostly occurs when cancer-fighting antibodies mistakenly attack normal cells in the nervous system. The prevalence of this disorder can be typically see…- 世界のアスペルガー症候群治療市場規模・現状・予測（2021年-2027年） The Asperger syndrome is a type of developmental disorders known as Autistic Spectrum Disorder (ASD). These disorders initiate in childhood and stay with individuals until their adult life. Children with the Asperger syndrome function better than those with autism, and they have normal intelligence …
- 世界のゾリンジャー-エリソン症候群検査市場規模・現状・予測（2021年-2027年） Zollinger-Ellison syndrome is a rare condition in which one or more tumors form in your pancreas or the upper part of your small intestine (duodenum). Market Analysis and Insights: Global Zollinger - Ellison Syndrome Testing Market The global Zollinger - Ellison Syndrome Testing market size is proj…
- 世界のリウマチ性腫瘍随伴症候群治療市場規模・現状・予測（2021年-2027年） A paraneoplastic syndrome is a rare group of disorder that is triggered by an abnormal immune system response caused by the neoplasm. This syndrome mostly occurs when cancer-fighting antibodies mistakenly attack normal cells in the nervous system. The prevalence of this disorder can be typically see…
- 世界のスタージーウェーバー症候群（SWS）治療市場規模・現状・予測（2021年-2027年） Sturge-Weber syndrome or Sturge-Weber-Krabbe disease, sometimes referred to as encephalotrigeminal angiomatosis, is a rare congenital neurological and skin disorder. It is one of the phakomatoses and is often associated with port-wine stains of the face, glaucoma, seizures, mental retardation, and i…